TY  - CONF

T1  - Adjuvant denosumab in early breast cancer: First results from the international multicenter randomized phase III placebo controlled D-CARE study.

JO  - Journal of Clinical Oncology

PY  - 2018/05/20

AU  - Coleman RE

AU  - Finkelstein D

AU  - Barrios CH

AU  - Martin M

AU  - Iwata H

AU  - Glaspy JA

AU  - Zhou Y

AU  - Jandial D

AU  - Chan A

ED  - 

DO  - DOI: 10.1200/jco.2018.36.15_suppl.501

PB  - American Society of Clinical Oncology (ASCO)

VL  - 36

IS  - 15_suppl

SP  - 501

EP  - 501

Y2  - 2025/10/10

ER  -